- Supported exchanges /
- KO /
- 185750.KO
Chong Kun Dang Pharmaceutical (185750 KO) stock market data APIs
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Chong Kun Dang Pharmaceutical Financial Data Overview
| 95700 | |
| 94400 | |
| - | |
| 95800 | |
| 93800 | |
| 93400-136500 | |
| 1 198 521 M | |
| 12 629 K | |
| 1 666 522 M | |
| 1725.6882 | |
| 0.0117 | |
| 0.823 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Chong Kun Dang Pharmaceutical Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 666 522 M
- EBITDA 274 307 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Chong Kun Dang Pharmaceutical Earnings via APIs
- Latest Release 2024-10-25
- EPS/Forecast 1487.89
Get Chong Kun Dang Pharmaceutical End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
